HuGE Navigator logo   HuGE Navigator (version 1.4)
   An integrated, searchable knowledge base of genetic associations and human genome epidemiology.
line
 HuGE Navigator > HuGE Literature Finder  Last data upload: 21 Jul 2010. (Total 52915 articles)  
HuGE Literature Finder
Data collected since 2001

Home  |  About  |  Search Instructions |  FAQs 

Search  
 for
Search Criteria: Meta-analysis and cancer[Text+MeSH] [Query Detail]

Filtered By  

Articles 1 - 25 of 513
Export Display on    of 21
1.
BRAF mutation predicts resistance to anti-EGFR monoclonal antibodies in wild-type KRAS metastatic colorectal cancer. [Detail]
Journal of cancer research and clinical oncology 2010 Aug 136 (8): 8.
Mao C, Liao RY, Chen Q
2.
PPARgamma polymorphisms and cancer risk: a meta-analysis involving 32,138 subjects. [Detail]
Oncology reports 2010 Aug 24 (2): 2.
Xu W, Li Y, Wang X, Chen B, Liu S, Wang Y, Zhao W, Wu J
3.
Association between two polymorphisms of ABCB1 and breast cancer risk in the current studies: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jul .
Lu PH, Wei MX, Yang J, Liu X, Tao GQ, Shen W, Chen MB
4.
RAD51 135G>C polymorphism and breast cancer risk: a meta-analysis. [Detail]
Breast cancer research and treatment 2010 Jul .
Zhou GW, Hu J, Peng XD, Li Q
5.
TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. [Detail]
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2010 Jul 19 (7): 7.
Dahabreh IJ, Linardou H, Bouzika P, Varvarigou V, Murray S
6.
A functional -77T>C polymorphism in XRCC1 is associated with risk of breast cancer. [Detail]
Breast cancer research and treatment 2010 Jun .
Liu L, Yuan P, Liu L, Wu C, Zhang X, Guo H, Zhong R, Xu Y, Wu J, Duan S, Rui R, Wu T, Nie S, Miao X, Lin D
7.
Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan. [Detail]
Oncology reports 2010 Jun 23 (6): 6.
Okazaki I, Sugita M, Matsuki H, Billah SM, Watanabe T
8.
Cyclin D1 G870A Polymorphism Is Associated with Risk and Clinicopathologic Characteristics of Bladder Cancer. [Detail]
DNA and cell biology 2010 Jun .
Yuan L, Gu X, Shao J, Wang M, Wang M, Zhu Q, Zhang Z
9.
CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis. [Detail]
World journal of gastroenterology : WJG 2010 Jun 16 (23): 23.
Zhou GW, Hu J, Li Q
10.
Dose-Dependent Association Between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk. [Detail]
Clinical cancer research : an official journal of the American Association for Cancer Research 2010 Jun .
Hu ZY, Yu Q, Pei Q, Guo C
11.
Genome-Wide Association Studies of Pigmentation and Skin Cancer: A Review and Meta-Analysis. [Detail]
GWAS Integrator
Pigment cell & melanoma research 2010 Jun .
Gerstenblith M, Shi J, Landi M
12.
Glutathione S-transferase T1 gene deletion polymorphism and lung cancer risk in Chinese population: A meta-analysis. [Detail]
Cancer epidemiology 2010 Jun .
Wang Y, Yang H, Li L, Wang H
13.
Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium. [Detail]
PLoS genetics 2010 6 (6): 6.
Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, Gu K, Wang W, Xiang YB, Cheng J, Chen K, Zhang L, Zheng H, Shen CY, Huang CS, Hou MF, Shen H, Hu Z, Wang F, Deming SL, Kelley MC, Shrubsole MJ, Khoo US, Chan KY, Chan SY, Haiman CA, Henderson BE, Le Marchand L, Iwasaki M, Kasuga Y, Tsugane S, Matsuo K, Tajima K, Iwata H, Huang B, Shi J, Li G, Wen W, Gao YT, Lu W, Zheng W
14.
Lack of association between ATM C.1066-6T > G mutation and breast cancer risk: a meta-analysis of 8,831 cases and 4,957 controls. [Detail]
Breast cancer research and treatment 2010 Jun .
Ding H, Mao C, Li SM, Liu Q, Lin L, Chen Q
15.
Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls. [Detail]
Breast cancer research and treatment 2010 Jun 121 (3): 3.
Mao C, Wang XW, Qiu LX, Liao RY, Ding H, Chen Q
16.
Pooled analysis of the association of PTGS2 rs5275 polymorphism and NSAID use with invasive ovarian carcinoma risk. [Detail]
Cancer causes & control : CCC 2010 Jun .
Lurie G, Terry KL, Wilkens LR, Thompson PJ, McDuffie KE, Carney ME, Palmieri RT, Cramer DW, Goodman MT
17.
Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial. [Detail]
Breast cancer research and treatment 2010 Jun .
Chen Y, Pei J
18.
Potentially functional COX-2-1195G>A polymorphism increases the risk of digestive system cancers: a meta-analysis. [Detail]
Journal of gastroenterology and hepatology 2010 Jun 25 (6): 6.
Dong J, Dai J, Zhang M, Hu Z, Shen H
19.
Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies. [Detail]
European journal of cancer (Oxford, England : 1990) 2010 Jun .
Qiu LX, Mao C, Zhang J, Zhu XD, Liao RY, Xue K, Li J, Chen Q
20.
Prostate cancer risk-associated variants reported from genome-wide association studies: Meta-analysis and their contribution to genetic Variation. [Detail]
The Prostate 2010 Jun .
Kim ST, Cheng Y, Hsu FC, Jin T, Kader AK, Zheng SL, Isaacs WB, Xu J, Sun J
21.
Relationship between XRCC3 T241M polymorphism and gastric cancer risk: a meta-analysis. [Detail]
Medical oncology (Northwood, London, England) 2010 Jun .
Fang F, Wang J, Yao L, Yu XJ, Yu L, Yu L
22.
TP53 Arg72Pro polymorphism and endometrial cancer risk: a meta-analysis. [Detail]
Medical oncology (Northwood, London, England) 2010 Jun .
Jiang DK, Yao L, Ren WH, Wang WZ, Peng B, Yu L
23.
VEGF 936C>T polymorphism and breast cancer risk: evidence from 5,729 cases and 5,868 controls. [Detail]
Breast cancer research and treatment 2010 Jun .
Gu D, Wang M
24.
Lack of an association between AURKA T91A polymorphisms and breast cancer: a meta-analysis involving 32,141 subjects. [Detail]
Breast cancer research and treatment 2010 May .
Sun H, Bai J, Chen F, Jin Y, Yu Y, Fu S
25.
RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies. [Detail]
Breast cancer research and treatment 2010 May .
Yu KD, Yang C, Fan L, Chen AX, Shao ZM
Export Display 25 on page   1 of  21
Articles 1 - 25 of 513